Health
LumaCyte Awarded Frost & Sullivan 2019 Global Single-Cell Analysis New Product Innovation Award for Its Novel Laser Force Cytology™ Technology
LumaCyte's Radiance platform has broad capabilities aiding in real-time label-free characterization of single-cells giving rise to better understanding of cellular systems and improving process optimization SANTA CLARA, California, Jan. 7, 2020 /PRNewswire/ -- Based on its recent analysis of the...
2020-01-07 20:07
850
Continued Success of Novoheart to Receive R&D Grants: Innovation Technology Fund for Developing Smart Cardiac Screening Technologies
* Grant will fund advanced R&D and incorporation of artificial intelligence (AI) technology to accelerate drug development using Novoheart's bio-engineered human heart chambers and tissues * Potential advancements expected to increase scale and capabilities of Novoheart's MyHeart™ Platform an...
2020-01-07 17:39
2776
Mundipharma Announces Exclusive Deal for Biosolution's CartiLife(R) in South Korea
SINGAPORE, Jan. 7, 2020 /PRNewswire/ -- Mundipharma has announced today that it has sealed an exclusive sales agreement with Biosolution Co., Ltd, a Korea-based leader in cell-based biotechnology, to market and distribute its fourth-generation autologous chondrocyte implantation product, CartiLif...
2020-01-07 11:37
3106
SIT Offers Singapore's First Undergraduate Degrees in Speech and Language Therapy and Digital Communications and Integrated Media in AY2020
SINGAPORE, Jan. 7, 2020 /PRNewswire/ -- In line with the university's mission to offer applied degree programmes targeted at growth sectors of the economy, the Singapore Institute of Technology (SIT) will launch two new degree programmes in Academic Year 2020/2021 - Bachelor of Science with Honou...
2020-01-07 11:00
1285
genOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models
genOway acquires additional rights to develop all animal cell models using the CRISPR/Cas9 system LYON, France, Jan. 7, 2020 /PRNewswire/ -- genOway, a public company and leader in developing genetically modified research models, today announced an important milestone in extending its strategic ...
2020-01-07 09:00
3007
InxMed Announces Clinical Collaboration with MSD to Evaluate IN10018 in Combination with Pembrolizumab
SHANGHAI, Jan. 7, 2020 /PRNewswire/ -- InxMed (Shanghai) Co., Ltd., a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, today announced that the company has entered into a clinical collaboration with a subsidiary of Merck & C...
2020-01-07 08:25
3393
Japanese Clinical Study of DiscGenics' Cell Therapy for Disc Degeneration Passes Initial Safety Review
SALT LAKE CITY and TOKYO, Jan. 7, 2020 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that IDCT has p...
2020-01-07 08:00
1439
Transcenta to Present at the 38th Annual J.P. Morgan Healthcare Conference
HONG KONG, SUZHOU, China and HANGZHOU, China, Jan. 6, 2020 /PRNewswire/ -- Transcenta Holding (Transcenta) today announced that Co-founder & CEO Dr. Xueming Qian will present at the 38th Annual J.P. Morgan Healthcare Conference onWednesday, January 15, 2020, at 14:30 PST in Golden Gate room at Wes...
2020-01-07 00:00
1302
Presagen and Life Whisperer Announce Call-out for a Global IVF Clinic Collaboration at CES 2020
SAN MATEO, Calif. and ADELAIDE, Australia, Jan. 6, 2020 /PRNewswire/ -- Life Whisperer, the fertility arm of AI healthcare company Presagen, which operates out ofSan Mateo and South Australia, recently presented the results of groundbreaking research at the prestigious American Society for Reprod...
2020-01-06 23:47
1413
Happiness Biotech Announces the Opening of its First Experience Store in Hainan, China, introducing the Company's 31st Experience Store
NANPING, China, Jan. 6, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today the opening of its first experience store inHainan, China, which is the Company's 31st experience ...
2020-01-06 21:00
9452
Inovio Provides Update on Clinical Program Plans for 2020
Inovio to present 2020 program plans at Biotech Showcase 2020 Conference PLYMOUTH MEETING, Pennsylvania, Jan. 6, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced that Inovio's President & CEO, Dr. J. Joseph Kim will present a corporate update of the company's clinical progr...
2020-01-06 21:00
2976
Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer
SHANGHAI and PHILADELPHIA, Jan. 6, 2020 /PRNewswire/ -- Antengene Corporation today announced its appointment of Mr.John Chin, MBA, as Chief Business Officer (CBO). He will be responsible for the company's global business development and commercialization, and will report directly to Dr.Jay Mei, ...
2020-01-06 20:00
3680
BAVENCIO Significantly Improved Overall Survival in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Not intended for US-, Canada- and UK-based media - At the planned interim analysis, Phase III JAVELIN Bladder 100 study met the primary endpoint of prolonging overall survival (OS) as a first-line maintenance treatment versus standard of care - BAVENCIO is the first immunotherapy to signifi...
2020-01-06 20:00
4759
12th Consecutive Year Leading United States in Organ Donation for Gift of Life Donor Program
PHILADELPHIA, Jan. 6, 2020 /PRNewswire/ -- For the 12th consecutive year, Gift
of Life Donor Program is the nation's leading organ procurement organization
(OPO), coordinating the most life-saving organs for transplant among all 58
U.S. OPOs.
2020-01-06 20:00
2844
Dr. Nalini Rajamannan Comments on FDA Congressional Letter to Senate Finance Committee After Kaiser Health News Reveals Access to Exempt FDA Database
SHEBOYGAN, Wis., Jan. 6, 2020 /PRNewswire/ -- Dr. Nalini Rajamannan -- a specialist for patients with valvular heart disease in Most Sacred Heart of Jesus Cardiology,Sheboygan, WI -- confirms today that patients finally may get answers about whether medical devices placed in their bodies are test...
2020-01-06 19:00
1351
Lianluo Smart Announces Receipt of Nasdaq Non-compliance of Stockholders' Equity Notification
BEIJING, Jan. 6, 2020 /PRNewswire/ -- Lianluo Smart Limited (the "Company") announced today that it has received a letter from the staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") onJanuary 2, 2020, providing notification that the Company no longer complies with the minimum of$2.5 mi...
2020-01-06 19:00
9887
CARsgen Appoints Yong Fan as Senior Vice President of Global Regulatory Affairs
SHANGHAI, Jan 6, 2020 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, today announced appointment ofYong Fan, MD, as Senior Vice President, Global Regulatory Affairs. Dr. Fan, will be responsible for CAR...
2020-01-06 18:00
3936
Abcam Announces Successful Acquisition of Expedeon's Proteomics and Immunology Business, Enhancing Its Conjugation Capability
- Includes leading protein conjugation technologies and industry brands Lightning-Link® and CaptSure™ - Opportunity to combine Expedeon and Abcam's technologies to create new products to support research and diagnostic development CAMBRIDGE, England, Jan. 6, 2020 /PRNewswire/ -- Abcam plc, a glo...
2020-01-06 15:00
999
GPHL's international headquarters settle in Macao, first project during the fifth-term government of Macao SAR
GUANGZHOU, China, Jan. 6, 2020 /PRNewswire/ -- The beginning of 2020 witnessed key projects promoting the cooperation betweenGuangdong and Macao. On January 3 , Guangzhou Pharmaceutical Group (Macau) International Development Co., Ltd. (hereunder referred to as "the company") was established inMac...
2020-01-06 14:39
1339
Nunaps raises US$4.2M to develop patient-centered digital therapeutics platform for brain damage
SEOUL, South Korea, Jan. 5, 2020 /PRNewswire/ -- Nunaps, a South Korean digital therapeutics startup, has closed aKRW 5 billion (US$ 4.2 million) Series A round by Company K Partners, KTB Network, and K2 Investment Partners. The company plans to use the fresh capital to build digital therapeutics...
2020-01-06 12:54
1239
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5214
